Scopia Capital Management’s Halozyme HALO Stock Holding History

Scopia Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-739,479	Closed	-$13.1M	–	29
2019 Q4	$13.1M	Buy	+739,479	New	+$12.8M	1.02%	17

Other funds holding HALO

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Scopia Capital Management's HALO Position: Q1 2020 in Review

Scopia Capital Management sold out of Halozyme (HALO) in Q1 2020, closing a stake of 739,479 shares — an estimated $13.1M sold.

Scopia Capital Management first reported a position in HALO in Q4 2019 and held it in 1 quarter. The position peaked at $13.1M in Q4 2019. 209 funds tracked by Wall St. Rank hold HALO as of Q1 2020.

Scopia Capital Management reported no remaining Halozyme position as of Q1 2020 after selling out during the quarter.
Scopia Capital Management sold 739,479 Halozyme shares in Q1 2020, an estimated $13.1M.
Scopia Capital Management first reported a position in Halozyme in Q4 2019 and held it in 1 quarter.
Scopia Capital Management's Halozyme position peaked at $13.1M in Q4 2019.
209 funds tracked by Wall St. Rank held Halozyme as of Q1 2020.

Based on Scopia Capital Management's 13F filing for Q1 2020, filed 15 May 2020.